(Q33768454)

29 July 2017

title

Experimental validation of a fragment library for lead discovery using SPR biosensor technology (English)

1 reference

29 July 2017

0 references

Malin Elinder

1

1 reference

29 July 2017

Matthis Geitmann

2

1 reference

29 July 2017

Thomas Gossas

3

1 reference

29 July 2017

Per Källblad

4

1 reference

29 July 2017

Johan Winquist

5

1 reference

29 July 2017

Helena Nordström

6

1 reference

29 July 2017

Markku Hämäläinen

7

1 reference

29 July 2017

U Helena Danielson

8

1 reference

29 July 2017

publication date

13 December 2010

1 reference

Journal of Biomolecular Screening

29 July 2017

published in

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

15-25

1 reference

A decade of fragment-based drug design: strategic advances and lessons learned

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Fragment-based drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Fragment-based screening using surface plasmon resonance technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Fragment library screening and lead characterization using SPR biosensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Relationships between Molecular Complexity, Biological Activity, and Structural Diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Molecular complexity and its impact on the probability of finding leads for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Library design for fragment based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

A ‘Rule of Three’ for fragment-based lead discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

ZINC--a free database of commercially available compounds for virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Screening for NNRTIs with slow dissociation and high affinity for a panel of HIV-1 RT variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Pursuing the leadlikeness concept in pharmaceutical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Property-based design: optimization of drug absorption and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

The properties of known drugs. 1. Molecular frameworks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Characteristic physical properties and structural fragments of marketed oral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Nonleadlikeness and leadlikeness in biochemical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110389038

21 January 2018

Identifiers

DOI

10.1177/1087057110389038

1 reference

29 July 2017

1 reference